Trial intelligence / Profile preview

CPC Mouthwash for Prevention of vURTI in Nursing Home Residents

NCT06251089Completed

Sponsor
Dentaid
Start
Nov 2023
Primary completion
Aug 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in viral upper respiratory tract infection comparing 0.07% CPC mouthwash with Placebo (2 arms). Primary endpoint: Occurrence of viral upper respiratory tract infection episodes at 3 months. Started Nov 2023; status: completed.

02

Drugs

cetylpyridinium chloride
03

Conditions

viral upper respiratory tract infection

Beyond the preview

Go deeper on NCT06251089.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06251089.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call